Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis--a new target for future therapy.

Nilesh M Pandya1, Naranjan S Dhalla, Dev D Santani

  • 1Department of Pharmacology, C. U. Shah College of Pharmacy and Research, Wadhwan City-363030, Dist. Surendranagar, India. pandyapharmacist@rediffmail.com

Vascular Pharmacology
|March 21, 2006
PubMed
Summary

Angiogenesis, the growth of new blood vessels, is crucial for development and repair but can drive diseases like cancer. Therapeutic targeting of angiogenesis, particularly via vascular endothelial growth factor (VEGF), offers clinical potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology and pharmacotherapy of cardiovascular complications in metabolic syndrome.

Journal of molecular and cellular cardiology·2026
Same author

Metabolic therapy for cardiovascular diseases with propionyl L-carnitine.

Canadian journal of physiology and pharmacology·2026
Same author

Improvement of Cardiac Function by Polyclonal Antibodies Against Ca<sup>2+</sup>/Mg<sup>2+</sup> ecto-ATPase in Hearts Subjected to Ischemia-Reperfusion.

International journal of molecular sciences·2026
Same author

The Role of Advanced Glycation End-Products in the Pathophysiology and Pharmacotherapy of Cardiovascular Disease.

International journal of molecular sciences·2025
Same author

Involvement of Oxidative Stress in Mitochondrial Abnormalities During the Development of Heart Disease.

Biomedicines·2025
Same author

Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury.

Antioxidants (Basel, Switzerland)·2025

Area of Science:

  • Cardiovascular Biology
  • Oncology
  • Developmental Biology

Background:

  • Angiogenesis, the formation of new blood vessels from existing ones, is vital for tissue repair, development, and reproduction.
  • Dysregulated angiogenesis contributes to pathologies including cancer, retinopathies, and coronary artery disease.
  • A delicate balance of pro- and anti-angiogenic factors controls blood vessel formation.

Purpose of the Study:

  • To review the role of angiogenesis in physiological and pathological processes.
  • To highlight the therapeutic potential of modulating angiogenesis.
  • To emphasize the critical role of vascular endothelial growth factor (VEGF) in angiogenesis.

Main Methods:

  • Literature review of angiogenesis mechanisms and therapeutic targets.

Related Experiment Videos

  • Analysis of the role of key angiogenic factors, including VEGF.
  • Examination of clinical applications for angiogenesis inhibition and stimulation.

    • Main Results:

    • Vascular endothelial cell growth factor (VEGF) is a key regulator of endothelial cell proliferation, permeability, and survival.
    • Inhibition of angiogenesis can treat diseases like cancer and arthritis.
    • Stimulation of angiogenesis is beneficial for conditions such as coronary artery disease and tissue injury.

    Conclusions:

    • Therapeutic manipulation of angiogenesis holds significant clinical promise for diverse diseases.
    • Targeting VEGF offers a potential strategy for treating angiogenesis-dependent pathologies.
    • Balancing angiogenic processes is critical for maintaining health and treating disease.